Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age18+
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

About this trial

The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.

Eligibility criteria

Qualifiers

18 years or older

willing and able to provide informed consent

postoperative urinary retention as defined by a failed RGVT prior to hospital discharge

Ability to speak and read English

Disqualifiers

allergy/intolerance to Tamsulosin or sulfa drugs

preoperative history of urinary retention as defined by preoperative post void residual of >150mL

current use of alpha antagonist medication for hypertension

severe dementia

Trial design

Treatments tested in this trial

  • Tamsulosin
  • Placebo

Treatment groups

154 Participants
are divided into 2 treatment groups